Human Uric Acid Transporter 1 (hURAT1): An Inhibitor Structure–Activity Relationship (SAR) Study

REFERENCES

• Becker , M. A. and Jolly , M. 2006 . Hyperuricemia and associated diseases . Rheum. Dis. Clin. N. Am. , 32 : 275 – 293 .
   PubMed Web of Science ®Google Scholar
• Anzai , N. , Kanai , Y. and Endou , H. 2007 . New insights into renal transport of urate . Curr. Opin. Rheumatol. , 19 : 151 – 157 .
   PubMed Web of Science ®Google Scholar
• Kutzing , M. K. and Firestein , B. L. 2008 . Altered uric acid levels and disease states . J. Pharmacol. Exp. Ther. , 324 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Shin , H. J. , Takeda , M. , Enomoto , A. , Fujimura , M. , Miyazaki , H. , Anazi , N. and Endou , H. 2011 . Interactions of urate transporter URAT1 in human kidney with uricosuric drugs . Nephrology , 16 : 156 – 162 .
   PubMed Web of Science ®Google Scholar
• Enomoto , A. , Kimura , H. , Chairoungdua , A. , Shigeta , Y. , Jutabha , P. , Cha , S. H. , Hosoyamada , M. , Takeda , M. , Sekine , T. , Igarashi , T. , Matsuo , H. , Kikuchi , Y. , Oda , T. , Ichida , K. , Hosoya , T. , Shimokata , K. , Niwa , T. , Kanai , Y. and Endou , H. 2002 . Molecular identification of a renal urate anion exchanger that regulates blood urate levels . Nature , 417 : 447 – 452 .
   PubMed Web of Science ®Google Scholar
• Roch-Ramel , F. and Guisan , B. 1999 . Renal transport of urate in humans . News Physiol. Sci. , 14 : 80 – 84 .
   PubMedGoogle Scholar
• Mount , D. B. , Kwon , C. Y. and Zandi-Nejad , K. 2006 . Renal urate transport . Rheum. Dis. Clin. N. Am. , 32 : 313 – 331 .
   PubMed Web of Science ®Google Scholar
• Huls , M. , Brown , C. D.A. , Windass , A. S. , Sayer , R. , van den Heuvel , J. J.M.W. , Heemskerk , S. , Russel , F. G.M. and Masereeuw , R. 2008 . The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane . Kidney Int. , 73 : 220 – 225 .
   PubMed Web of Science ®Google Scholar
• Woodward , O. M. , Köttgen , A. , Coresh , J. , Boerwinkle , E. , Guggino , W. B. and Köttgen , M. 2009 . Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout . PNAS , 106 : 10338 – 10342 .
   PubMed Web of Science ®Google Scholar
• Jutabha , P. , Anzai , N. , Kitamura , K. , Taniguchi , A. , Kaneko , S. , Yan , K. , Yamada , H. , Shimada , H. , Kimura , T. , Katada , T. , Fukutomi , T. , Tomita , K. , Urano , W. , Yamanaka , H. , Seki , G. , Fujita , T. , Moriyama , Y. , Yamada , A. , Uchida , S. , Wempe , M. F. , Endou , H. and Sakurai , H. 2010 . Human sodium-phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate . J. Biol. Chem. , 285 : 35123 – 35132 .
   PubMed Web of Science ®Google Scholar
• Anzai , N. , Ichida , K. , Jutabha , P. , Kimura , T. , Babu , E. , Jin , C. J. , Srivastava , S. , Kitamura , K. , Hisatome , I. , Endou , H. and Sakurai , H. 2008 . Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans . J. Biol. Chem. , 283 : 26834 – 26838 .
   PubMed Web of Science ®Google Scholar
• Caulfield , M. J. , Munroe , P. B. , O’Neill , D. , Witkowska , K. , Charchar , F. J. , Doblado , M. , Evans , S. , Eyheramendy , S. , Onipinla , A. , Howard , P. , Shaw-Hawkins , S. , Dobson , R. J. , Wallace , C. , Newhouse , S. J. , Brown , M. , Connell , J. M. , Dominiczak , A. , Farrall , M. , Lathrop , G. M. , Samani , N. J. , Kumari , M. , Marmot , M. , Brunner , E. , Chambers , J. , Elliott , P. , Kooner , J. , Laan , M. , Org , E. , Veldre , G. , Viigimaa , M. , Cappuccio , F. P. , Ji , C. , Lacone , R. , Strazzullo , P. , Moley , K. H. and Cheeseman , C. 2008 . SLC2A9 is a high-capacity urate transporter in humans . PLoS Med , 5 : e197
   PubMed Web of Science ®Google Scholar
• Sekine , T. , Watanabe , N. , Hosoyamada , M. , Kanai , Y. and Endou , H. 1997 . Expression cloning and characterization of a novel multispecific organic anion transporter . J. Biol. Chem. , 272 : 18526 – 18529 .
   PubMed Web of Science ®Google Scholar
• Saag , K. G. and Choi , H. 2006 . Epidemiology, risk factors, and lifestyle modifications for gout . Arthr. Res. Ther. , 8 ( Suppl. 1:S2 )
   PubMedGoogle Scholar
• Feig , D. I. , Kang , D. H. and Johnson , R. J. 2008 . Uric acid and cardiovascular risk . N. Engl. J. Med. , 359 : 1811 – 1821 .
   PubMed Web of Science ®Google Scholar
• Anzai , N. , Jutabha , P. and Endou , H. 2010 . Renal solute transporters and their relevance to serum urate disorder . Curr. Hypertens. Rev. , 6 : 148 – 154 .
   Google Scholar
• Wempe , M. F. , Jutabha , P. , Quade , B. , Iwen , T. J. , Frick , M. M. , Rice , P. J. , Anzai , N. and Endou , H. 2011 . Developing potent human uric acid transporter 1 (hURAT1) inhibitor . J. Med. Chem. , 54 : 2701 – 2713 .
   PubMed Web of Science ®Google Scholar
• Frisch , M. J. , Trucks , G. W. , Schlegel , H. B. , Scuseria , G. E. , Robb , M. A. , Cheeseman , J. R. , Montgomery , J. A. , Vreven , T. , Kudin , K. N. and Burant , J. C. 2003 . Gaussian 03 Revision C.02 , Wallingford, CT : Gaussian, Inc. .
   Google Scholar
• Hehre , W. J. , Stewart , R. F. and Pople , J. A. 1969 . Self-consistent molecular-orbital methods. I. Use of Gaussian expansions of Slater-type atomic orbitals . J. Chem. Phys. , 51 : 2657 – 2665 .
   Web of Science ®Google Scholar
• Collins , J. B. , Schleyer , PvR. , Binkley , J. S. and Pople , J. A. 1976 . Self-consistent molecular orbital methods. XVII. Geometries and binding energies of second-row molecules. A comparison of three basis sets . J. Chem. Phys. , 64 : 5142 – 5151 .
   Web of Science ®Google Scholar
• Smith , M. B. and March , J. 2007 . March's Advanced Organic Chemistry Reactions, Mechanisms, and Structure , 6th ed. , 107 – 109 . John Wiley & Sons, Inc., Hoboken, NJ .
   Google Scholar